Drug Profile
Hydrocodone/paracetamol immediate release - Teva Pharmaceutical
Alternative Names: Acetaminophen/hydrocodone bitartarate - Teva Pharmaceutical; TV-46763Latest Information Update: 31 May 2018
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class Acetanilides; Morphine derivatives; Non-opioid analgesics; Opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor agonists; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 01 May 2016 Teva Pharmaceutical completes a phase III trial in Pain (Abuse-resistant) in USA (NCT02487108)
- 31 Aug 2015 Phase-III clinical trials in Pain (Abuse-resistant) in USA (PO)
- 08 Jul 2015 Teva Pharmaceutical plans a phase III trial in Pain (In adults, In the elderly) in USA (NCT02487108)